These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30116551)

  • 1. Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations.
    Cowan J; Mulpuru S; Aaron S; Alvarez G; Giulivi A; Corrales-Medina V; Thiruganasambandamoorthy V; Thavorn K; Mallick R; Cameron DW
    Pilot Feasibility Stud; 2018; 4():135. PubMed ID: 30116551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD.
    Cowan J; Mulpuru S; Abdallah SJ; Chopra A; Purssell A; McGuinty M; Alvarez GG; Giulivi A; Corrales-Medina V; MacFadden D; Boyle L; Hasimja D; Thavorn K; Mallick R; Aaron SD; Cameron DW
    Int J Chron Obstruct Pulmon Dis; 2021; 16():3275-3284. PubMed ID: 34887657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sequential treatment with syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and "AECOPD Risk-Window": study protocol for a randomized placebo-controlled trial.
    Haifeng W; Jiansheng L; Suyun L; Xueqing Y; Hailong Z; Zhiwan W; Qiyi W; Pankui Z; Zhongchao W; Fenglei L; Haihong Y
    Trials; 2012 Apr; 13():40. PubMed ID: 22520863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III, two arm, multi-centre, open label, parallel-group randomised designed clinical investigation of the use of a personalised early warning decision support system to predict and prevent acute exacerbations of chronic obstructive pulmonary disease: 'Predict & Prevent AECOPD' - study protocol.
    Kaur D; Mehta RL; Jarrett H; Jowett S; Gale NK; Turner AM; Spiteri M; Patel N
    BMJ Open; 2023 Mar; 13(3):e061050. PubMed ID: 36914185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Chinese medicine on patients with acute exacerbations of COPD: study protocol for a randomized controlled trial.
    Zhang H; Li J; Yu X; Li S; Wang H; Ruan H; Si Y; Xie Y; Wang M
    Trials; 2019 Dec; 20(1):735. PubMed ID: 31842969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The feasibility of early pulmonary rehabilitation and activity after COPD exacerbations: external pilot randomised controlled trial, qualitative case study and exploratory economic evaluation.
    Cox M; O'Connor C; Biggs K; Hind D; Bortolami O; Franklin M; Collins B; Walters S; Wailoo A; Channell J; Albert P; Freeman U; Bourke S; Steiner M; Miles J; O'Brien T; McWilliams D; Schofield T; O'Reilly J; Hughes R
    Health Technol Assess; 2018 Mar; 22(11):1-204. PubMed ID: 29516853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating Acute EXacerbations of COPD with Chinese HerbAL MedIcine to aid AntiBiotic Use Reduction (EXCALIBUR): study protocol of a randomised double-blind, placebo-controlled feasibility trial.
    Hu XY; Oliver T; Willcox M; Simpson C; Thorne K; Trill J; Francis N; Stuart B; Thomas M; Little P; Liu JP; Griffiths G; Moore M
    Pilot Feasibility Stud; 2022 Dec; 8(1):262. PubMed ID: 36536462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial).
    Urwyler P; Boesing M; Abig K; Cattaneo M; Dieterle T; Zeller A; Bachler H; Markun S; Senn O; Merlo C; Essig S; Ullmer E; Rutishauser J; Schuurmans MM; Leuppi JD
    Trials; 2019 Dec; 20(1):727. PubMed ID: 31842993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
    Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
    Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial.
    Willcox ML; Hu XY; Oliver T; Thorne K; Boxall C; He G; Simpson C; Brotherwood B; O'Neil A; Waugh R; Tilt E; Trill J; Goward N; Francis N; Thomas M; Little P; Wilkinson T; Liu JP; Griffiths G; Moore M
    Front Pharmacol; 2023; 14():1221905. PubMed ID: 37818189
    [No Abstract]   [Full Text] [Related]  

  • 12. Proton pump inhibitors for chronic obstructive pulmonary disease.
    Kikuchi S; Imai H; Tani Y; Tajiri T; Watanabe N
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013113. PubMed ID: 32844430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of salvational intervention with ICS/LABA for reducing chronic obstructive pulmonary disease exacerbation under severe air pollution (SIRCAP) in Beijing: protocol of a multi-center randomized controlled trial.
    Zhou T; Zhong Y; Liao J; Wang G; Li X; Qian X; Xiang P; Chen X; Xu Z; Zhang F; Wang X; Wang S; Li X; Yu C; Zhang Y; Xia G; Dai L
    BMC Pulm Med; 2019 Jan; 19(1):22. PubMed ID: 30683080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sequential treatment with TCM syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and AECOPD risk window.
    Jiansheng L; Haifeng W; Suyun L; Hailong Z; Xueqing Y; Xiaoyun Z; Fengsen L; Xianmei Z; Zikai S; Yimin M; Lijun M; Yijie Z; Guojun Z; Bingxiang T
    Complement Ther Med; 2016 Dec; 29():109-115. PubMed ID: 27912934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruiting Patients After Hospital Discharge for Acute Exacerbation of COPD: Challenges and Lessons Learned.
    Ferguson GT; Beck B; Clerisme-Beaty E; Liu D; Thomashow BM; Wise RA; ZuWallack R; Make BJ
    Chronic Obstr Pulm Dis; 2017 Aug; 4(4):265-278. PubMed ID: 29354671
    [No Abstract]   [Full Text] [Related]  

  • 16. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.
    Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled study evaluating the efficacy of propolis and N-acetylcysteine in exacerbations of chronic obstructive pulmonary disease.
    Buha I; Mirić M; Agić A; Simić M; Stjepanović M; Milenković B; Nagorni-Obradović L; Škodrić-Trifunović V; Ilić B; Popević S; Dimic-Janjic S; Ilić A
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4809-4815. PubMed ID: 35856373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort study.
    Bourne S; Cohet C; Kim V; Barton A; Tuck A; Aris E; Mesia-Vela S; Devaster JM; Ballou WR; Clarke SC; Wilkinson T
    BMJ Open; 2014 Mar; 4(3):e004546. PubMed ID: 24607562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on stable chronic obstructive pulmonary disease: study protocol of a randomized, double-blind, placebo-controlled trial.
    Zu Y; Li D; Lei X; Zhang H
    Trials; 2019 Nov; 20(1):647. PubMed ID: 31775843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.